SCHEMBL25423247

SCHEMBL25423247

CCN(C)C(=O)C(=O)c1c[nH]c2cc(F)cc(F)c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.39
▸ RIPK1 Q13546 3/20 0.35
▸ GPR17 Q13304 1/20 0.33
▸ CDK4 P11802 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25748764 0.86 HTR1A (0.39) HTR1AGPR17ALDH1A1CES2CES1
SCHEMBL25436730 0.85 MAPK14 (0.38) HTR1ACDK4CCND1ALDH1A1KMT2A
SCHEMBL16135241 0.82 HTR2A (0.46) HTR1ACDK4CCND1
SCHEMBL25748782 0.82 HTR1A (0.36) HTR1AGPR17ALDH1A1CES2CES1
SCHEMBL30877820 0.79 ALDH1A1 (0.45) RIPK1CDK4CCND1ALDH1A1CES2
SCHEMBL29206539 0.79 ALDH1A1 (0.45) RIPK1CDK4CCND1ALDH1A1CES2
SCHEMBL25435471 0.79 GPR84 (0.43) HTR1AALDH1A1PRKAB2PRKAG1PRKAA2
SCHEMBL13325448 0.79 CES2 (0.38) HTR1AGPR17ALDH1A1CES2CES1
SCHEMBL25423559 0.78 GPR84 (0.41) ALDH1A1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL30483774 0.78 GPR84 (0.41) ALDH1A1PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB HTR1A 185/4885RIPK1 4089/4885GPR17 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback